|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 2024 | The Boosting | BECKER, Thijs; GEUBBELMANS, Melvin; ROUSSEAU, Axel-Jan; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A2 |
| 2 | 2024 | Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer | Kokot, Anna; Gadakh, Sachin; Saha, Indrajit; Gajda, Ewa; Lazniewski, Michal; Rakshit, Somnath; Sengupta, Kaustav; Mollah, Ayatullah Faruk; Denkiewicz, Michal; GORCZAK, Katarzyna; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz; Plewczynski, Dariusz | Journal Contribution | A1 |
| 3 | 2023 | Over-accrual in Bayesian adaptive trials with continuous futility stopping | GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 4 | 2023 | Operational characteristics of univariate generalized pairwise comparisons with missing data | DELTUVAITE-THOMAS, Vaiva; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 5 | 2023 | Trial Design for Cancer Immunotherapy: A Methodological Toolkit | Saad, Everardo D.; Coart, Elisabeth; DELTUVAITE-THOMAS, Vaiva; GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 6 | 2023 | Availability of Third Molars as Donor Teeth for Autotransplantation to Replace Congenitally Absent Second Premolars in Children and Young Adults | Bilinska, Malgorzata; BURZYKOWSKI, Tomasz; Plakwicz, Pawel; Zadurska, Malgorzata; Czochrowska, Ewa Monika | Journal Contribution | A1 |
| 7 | 2023 | Generalized linear models | BURZYKOWSKI, Tomasz; GEUBBELMANS, Melvin; ROUSSEAU, Axel-Jan; VALKENBORG, Dirk | Journal Contribution | A2 |
| 8 | 2023 | Validation of machine learning algorithms | BURZYKOWSKI, Tomasz; GEUBBELMANS, Melvin; ROUSSEAU, Axel-Jan; VALKENBORG, Dirk | Journal Contribution | A2 |
| 9 | 2023 | Introduction to machine learning | BURZYKOWSKI, Tomasz; ROUSSEAU, Axel-Jan; GEUBBELMANS, Melvin; VALKENBORG, Dirk | Journal Contribution | A2 |
| 10 | 2023 | Support vector machines | VALKENBORG, Dirk; ROUSSEAU, Axel-Jan; GEUBBELMANS, Melvin; BURZYKOWSKI, Tomasz | Journal Contribution | A2 |
| 11 | 2023 | Decision trees and random forests | BECKER, Thijs; ROUSSEAU, Axel-Jan; GEUBBELMANS, Melvin; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 12 | 2023 | Minimization in randomized clinical trials | Coart, Elisabeth; Bamps, Perrine; Quinaux, Emmanuel; Sturbois, Geneviève; Saad, Everardo D; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 13 | 2023 | Generalized pairwise comparisons for censored data: An overview | DELTUVAITE-THOMAS, Vaiva; VERBEECK, Johan; BURZYKOWSKI, Tomasz; BUYSE, Marc; Tournigand, Christophe; MOLENBERGHS, Geert; THAS, Olivier | Journal Contribution | A1 |
| 14 | 2023 | High-dimensional data | GEUBBELMANS, Melvin; ROUSSEAU, Axel-Jan; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A2 |
| 15 | 2023 | Supervised learning | VALKENBORG, Dirk; GEUBBELMANS, Melvin; ROUSSEAU, Axel-Jan; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 16 | 2023 | Unsupervised learning | VALKENBORG, Dirk; ROUSSEAU, Axel-Jan; GEUBBELMANS, Melvin; BURZYKOWSKI, Tomasz | Journal Contribution | A2 |
| 17 | 2023 | Machine learning approach for the prediction of the number of sulphur atoms in peptides using the theoretical aggregated isotope distribution | AGTEN, Annelies; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 18 | 2022 | Relationship Among the Foraminal Area and Demographic and Clinical Characteristics of Patients with Low Back Pain | Lorenc , Tomasz; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 19 | 2022 | Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology | Goldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, Aimery | Journal Contribution | A1 |
| 20 | 2022 | Surrogacy Beyond Prognosis: The Importance of “Trial-Level” Surrogacy | BUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S. | Journal Contribution | A1 |
| 21 | 2022 | The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration | Jamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; BURZYKOWSKI, Tomasz; Saad, Everardo D; BUYSE, Marc | Journal Contribution | A1 |
| 22 | 2022 | Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints | DELTUVAITE-THOMAS, Vaiva; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 23 | 2022 | Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint | Barrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 24 | 2022 | Semi-parametric accelerated failure-time model: A useful alternative to the proportional-hazards model in cancer clinical trials | BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 25 | 2021 | Status of the alveolar bone after autotransplantation of developing premolars to the anterior maxilla assessed by CBCT measurements | Plakwicz, Pawel; Andreasen, Jens Ove; Gorska, Renata; BURZYKOWSKI, Tomasz; Czochrowska, Ewa | Journal Contribution | A1 |
| 26 | 2021 | Explanatory Model Analysis. Explore, Explain, and Examine Predictive Models | Biecek, Przemyslaw; BURZYKOWSKI, Tomasz | Book | B1 |
| 27 | 2021 | Evaluation of surrogate endpoints | MOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, Wim | Book Section | B2 |
| 28 | 2021 | Predicting the number of sulfur atoms in peptides and small proteins based on the observed aggregated isotope distribution | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 29 | 2020 | Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statistics | VERBEECK, Johan; DELTUVAITE-THOMAS, Vaiva; BERCKMOES, Ben; BURZYKOWSKI, Tomasz; AERTS, Marc; THAS, Olivier; BUYSE, Marc; MOLENBERGHS, Geert | Journal Contribution | A1 |
| 30 | 2020 | Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trials | Oba, Koji; Paoletto, Xavier; Bang, Yung-Jue; Bouche, Olivier; Ducreux, Michel; Michiels, Stefan; Moehler, MarkusH; Morita, Satoshi; Ohashi, Yasuo; Sakamoto, Junichi; Sasako, Mitsuru; Shitara, Kohei; Van Cutsem, Eric; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 31 | 2020 | Bayesian biomarker-driven outcome-adaptive randomization with an imperfect biomarker assay | GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 32 | 2020 | Meta-analytic approach to evaluation of surrogate endpoints | BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; SHKEDY, Ziv | Book Section | B2 |
| 33 | 2020 | Visualizing the agreement of peptide assignments between different search engines | AGTEN, Annelies; VAN HOUTVEN, Joris; Askenazi, M; BURZYKOWSKI, Tomasz; Laukens, K; VALKENBORG, Dirk | Journal Contribution | A1 |
| 34 | 2020 | The (generalized) hydrogen rule for organic molecules | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 35 | 2020 | A “Refined Hydrogen Rule” and a “Refined Hydrogen and Halogen Rule” for Organic Molecules | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 36 | 2019 | Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis | Saad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, Marc | Journal Contribution | A1 |
| 37 | 2019 | The impact of the method of extracting metabolic signal from H-1-NMR data on the classification of samples: A case study of binning and BATMAN in lung cancer | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; LOUIS, Evelyne; ADRIAENSENS, Peter; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 38 | 2019 | Detection of atypical data in multicenter clinical trials using unsupervised statistical monitoring | Trotta, Laura; Kabeya, Yuusuke; BUYSE, Marc; Doffagne, Erik; Venet, David; Desmet, Lieven; BURZYKOWSKI, Tomasz; Tsuburaya, Akira; Yoshida, Kazuhiro; Miyashita, Yumi; Morita, Satoshi; Sakamoto, Junichi; Praveen, Paurush; Oba, Koji | Journal Contribution | A1 |
| 39 | 2019 | A Poisson approach to the validation of failure time surrogate endpoints in individual patient data meta-analyses | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | A1 |
| 40 | 2019 | Joint modelling of a binary and a continuous outcome measured at two cycles to determine the optimal dose | Ezzalfani, Monia; BURZYKOWSKI, Tomasz; PAOLETTI, Xavier | Journal Contribution | A1 |
| 41 | 2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer | BURZYKOWSKI, Tomasz; Coart, E.; Saad, E.D.; Shi, Q.; Sommeijer, D.W.; Bokemeyer, C.; Díaz-Rubio, E.; Douillard, Jean-Yves; Falcone, A.; Fuchs, C.; Goldberg, R.M.; Hecht, R.; Hoff, P.M.; Hurwitz, H.; Kabbinavar, F.F.; Koopman, M.; Maughan, T.; Punt, C.J.A.; Saltz, L.; Schmoll, Hans-Joachim; Seymour, M.T.; Tebbutt, N.C.; Tournigand, C.; Van Cutsem, E.; de Gramont, A.; Zalcberg, J.R.; BUYSE, Marc | Journal Contribution | A1 |
| 42 | 2019 | The retrospective study of 93 patients with transmigration of mandibular canine and a comparative analysis with a control group | Plakwicz, Pawel; Abramczyk, Joanna; Wojtaszek-Lis, Julita; Sajkowska, Jolanta; Warych, Barbara; Gawron, Katarzyna; BURZYKOWSKI, Tomasz; Zadurska, Malgorzata; Czochrowska, Ewa Monika; Wojtowicz, Andrzej; Gorska, Renata; Kukula, Krzysztof | Journal Contribution | A1 |
| 43 | 2019 | Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLC | Rutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, Jacek | Journal Contribution | A1 |
| 44 | 2019 | A multivariate linear model for investigating the association between gene-module co-expression and a continuous covariate | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; SHKEDY, Ziv; Salo, Perttu; Perola, Markus; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 45 | 2019 | A Bayesian Framework Allowing Incorporation of Retrospective Information in Prospective Diagnostic Biomarker-Validation Designs | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 46 | 2019 | A Multivariate Negative-Binomial Model with Random Effects for Differential Gene-Expression Analysis of Correlated mRNA Sequencing Data | Kazakiewicz, D; CLAESEN, Jurgen; GORCZAK, Katarzyna; Plewczynski, D; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 47 | 2019 | A Conceptual Framework for Abundance Estimation of Genomic Targets in the Presence of Ambiguous Short Sequencing Reads | GORCZAK, Katarzyna; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 48 | 2019 | De novo prediction of the elemental composition of peptides and proteins based on a single mass | CLAESEN, Jurgen; VALKENBORG, Dirk; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 49 | 2019 | Experimental design in quantitative proteomics | BURZYKOWSKI, Tomasz; CLAESEN, Jurgen; VALKENBORG, Dirk | Book Section | B2 |
| 50 | 2018 | The search for surrogate endpoints for immunotherapy trials | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A2 |
| 51 | 2018 | Comprehensive analysis of cancer stemness | Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; BURZYKOWSKI, Tomasz; Poisson, Laila; Weinstein, John; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Colaprico, Antonio; Czerwinska, Patrycja; Mazurek, Sylwia; Mishra, Lopa; Heyn, Holger; Krasnitz, Alex; Godwin, Andrew K.; Lazar, Alexander J.; Stuart, Joshua M.; Hoadley, Katherine; Laird, Peter W.; Noushmehr, Houtan; Wiznerowicz, Maciej | Journal Contribution | M |
| 52 | 2018 | Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation | Malta, Tathiane M.; Sokolov, Artem; Gentles, Andrew J.; BURZYKOWSKI, Tomasz; Poisson, Laila; Weinstein, John N.; Kaminska, Bozena; Huelsken, Joerg; Omberg, Larsson; Gevaert, Olivier; Colaprico, Antonio; Czerwinska, Patrycja; Mazurek, Sylwia; Mishra, Lopa; Heyn, Holger; Krasnitz, Alex; Godwin, Andrew K.; Lazar, Alexander J.; Stuart, Joshua M.; Hoadley, Katherine A.; Laird, Peter W.; Noushmehr, Houtan; Wiznerowicz, Maciej | Journal Contribution | A1 |
| 53 | 2018 | Sequential double cross-validation for assessment of added predictive ability in high-dimensional omic applications | Rodriguez-Girondo, Mar; Salo, Perttu; BURZYKOWSKI, Tomasz; Perola, Markus; HOUWING-DUISTERMAAT, Jeanne; Mertens, Bart | Journal Contribution | A1 |
| 54 | 2018 | Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better? | Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 55 | 2018 | Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results | Mackiewicz, Jacek; BURZYKOWSKI, Tomasz; Izycki, Dariusz; Mackiewicz, Andrzej | Journal Contribution | A1 |
| 56 | 2018 | Statistical evaluation of surrogate endpoints in cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, K.; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Book Section | B2 |
| 57 | 2017 | Applied Surrogate Endpoint Evaluation Methods with SAS and R | ALONSO ABAD, Ariel; BIGIRUMURAME, Theophile; BURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; MUCHENE, Leacky; PERUALILA, Nolen Joy; SHKEDY, Ziv; VAN DER ELST, Wim | Book | B1 |
| 58 | 2017 | Evaluation of failure time surrogate endpoints in individual patient data meta-analyses of randomized clinical trials. A poisson approach | Rotolo, Federico; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc; Michiels, Stefan | Journal Contribution | M |
| 59 | 2017 | Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question | BURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, Marc | Journal Contribution | A1 |
| 60 | 2017 | Precision medicine needs randomized clinical trials | Saad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 61 | 2017 | Use of the Beta-Binomial Model for Central Statistical Monitoring of Multicenter Clinical Trials | Desmet, Lieven; Venet, David; Doffagne, Erik; Timmermans, Catherine; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 62 | 2017 | Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-test | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 63 | 2017 | An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number | Szutowicz-Zielinska, Ewa; Konopa, Krzysztof; Kowalczyk, Anna; Suszko-Kazarnowicz, Malgorzata; Duchnowska, Renata; Szczesna, Aleksandra; Ratajska, Magdalena; Sowa, Aleksander; Limon, Janusz; Biernat, Wojciech; BURZYKOWSKI, Tomasz; Jassem, Jacek; Dziadziuszko, Rafal | Journal Contribution | A1 |
| 64 | 2017 | The Analysis of Peptide-Centric Mass-Spectrometry Data Utilizing Information About the Expected Isotope Distribution | BURZYKOWSKI, Tomasz; CLAESEN, Jurgen; VALKENBORG, Dirk | Book Section | B2 |
| 65 | 2016 | Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial | Timmermans, Catherine; Doffagne, Erik; Venet, David; Desmet, Lieven; LEGRAND, Catherine; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 66 | 2016 | Statistical evaluation of surrogate endpoints with examples from cancer clinical trials | BUYSE, Marc; MOLENBERGHS, Geert; PAOLETTI, Xavier; Oba, Koji; ALONSO ABAD, Ariel; VAN DER ELST, Wim; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 67 | 2016 | Neoadjuvant as Future for Drug Development in Breast Cancer-Letter | BUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D. | Journal Contribution | A1 |
| 68 | 2016 | Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference test | GARCIA BARRADO, Leandro; Coart, Els; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 69 | 2016 | Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat | Sedel, Frédéric; Chabrol, Brigitte; Audoin, Bertrand; Kaphan, Elsa; Tranchant, Christine; BURZYKOWSKI, Tomasz; Tourbah, Ayman; Vanier, Marie T.; Galanaud, Damien | Journal Contribution | A1 |
| 70 | 2016 | COMPUTATIONAL METHODS AND CHALLENGES IN HYDROGEN/DEUTERIUM EXCHANGE MASS SPECTROMETRY | CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 71 | 2016 | The Detection of Metabolite-Mediated Gene Module Co-Expression Using Multivariate Linear Models | PADAYACHEE, Trishanta; KHAMIAKOVA, Tatsiana; SHKEDY, Ziv; Perola, Markus; Salo, Perttu; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 72 | 2016 | Adaptive Randomization of Neratinib in Early Breast Cancer | BUYSE, Marc; Saad, E.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 73 | 2016 | An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 74 | 2016 | Data-driven risk identification in phase III clinical trials using central statistical monitoring | Timmermans, Catherine; Venet, David; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 75 | 2015 | Event-Free Survival Is a Surrogate for Overall Survival in Patients Treated for Acute Myeloid Leukemia | Schlenk, Richard F.; Doehner, Hartmut; Doehner, Konstanze; Ganser, Arnold; Heuser, Michael; Benner, Axel; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | M |
| 76 | 2015 | Surrogate properties of survival endpoints in metastatic soft-tissue sarcoma: A meta-analysis. | Savina, Marion; LITIERE, Saskia; Penel, Nicolas; Rondeau, Virginie; BURZYKOWSKI, Tomasz; Toulmonde, Maud; Italiano, Antoine; Mathoulin-Pelissier, Simone; Bellera, Carine A. | Journal Contribution | M |
| 77 | 2015 | Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease | Coart, Els; GARCIA BARRADO, Leandro; Duits, Flora H.; Scheltens, Philip; van der Flier, Wiesje M.; Teunissen, Charlotte E.; van der Vies, Saskia M.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 78 | 2015 | A hidden Markov-model for gene mapping based on whole-genome next generation sequencing data | CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 79 | 2015 | A Nonhomogeneous Hidden Markov Model for Gene Mapping Based on Next-Generation Sequencing Data | ZAMANZAD GHAVIDEL, Fatemeh; CLAESEN, Jurgen; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 80 | 2015 | Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma | Jacek, Mackiewicz; Aldona, Karczewska-Dzionk; Maria, Laciak; Malgorzata, Kapcinska; Maciej, Wiznerowicz; BURZYKOWSKI, Tomasz; Zakowska, Monika; Stefan, Rose-John; Andrzej, Mackiewicz | Journal Contribution | A1 |
| 81 | 2015 | PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance | Stern, Howard M.; Gardner, Humphrey; BURZYKOWSKI, Tomasz; Elatre, Wafaa; O'Brien, Carol; Lackner, Mark R.; Pestano, Gary A.; Santiago, Angela; Villalobos, Ivonne; Eiermann, Wolfgang; Pienkowski, Tadeusz; Martin, Miguel; Robert, Nicholas; Crown, John; Nuciforo, Paolo; Bee, Valerie; Mackey, John; Slamon, Dennis J.; Press, Michael F. | Journal Contribution | A1 |
| 82 | 2015 | Transferring Cut-off Values between Assays for Cerebrospinal Fluid Alzheimer's Disease Biomarkers | GARCIA BARRADO, Leandro; Coart, Els; Vanderstichele, Hugo M. J.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 83 | 2015 | Differences in the Elemental Isotope Definition May Lead to Errors in Modern Mass-Spectrometry-Based Proteomics | CLAESEN, Jurgen; Lermyte, Frederik; Sobott, Frank; BURZYKOWSKI, Tomasz; VALKENBORG, Dirk | Journal Contribution | A1 |
| 84 | 2015 | On the relationship between the causal-inference and meta-analytic paradigms for the validation of surrogate endpoints | ALONSO ABAD, Ariel; VAN DER ELST, Wim; MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 85 | 2015 | Biomarker‑based surrogate endpoints | BUYSE, Marc; BURZYKOWSKI, Tomasz; MOLENBERGHS, Geert; ALONSO ABAD, Ariel | Book Section | B2 |
Loading...
5
0
5
0
false